Atlas Trials

Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation

Clinical trial NCT03246906 · TERMINATED

Trial details

NCT number
NCT03246906
Sponsor
Fred Hutchinson Cancer Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin LymphomaChronic Lymphocytic LeukemiaDiffuse Large B-Cell LymphomaMantle Cell LymphomaMyelodysplastic SyndromeMyelodysplastic/Myeloproliferative NeoplasmProlymphocytic LeukemiaRecurrent Chronic Lymphocytic LeukemiaRecurrent Chronic Myelogenous Leukemia, BCR-ABL1 PositiveRecurrent Hodgkin Lymphoma
Start date
2017-09-11
Primary completion
2025-05-03
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.